Toll Free: 1-888-928-9744
Published: Apr, 2018 | Pages:
120 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The global contrast media agents market size is estimated to reach USD 5.96 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.8% during the forecast period. Increasing burden of chronic diseases is augmenting diagnostic imaging procedure volumes, which is providing a fillip to the market. Competitive strategies, such as acquisitions and indication extensions for existent products, adopted by players are expected to trigger the growth of the market. The companies stirring changes in the space is restricted to few in number. Among these, Guerbet, GE Healthcare, and Bayer were the forerunners with top-selling drugs in their respective portfolios and commanding more than 40% share in 2016. Bayer holds a prominent position in the arena owing to its leading MRI agent, Gadavist/Gadovist, a macrocyclic gadolinium agent. Guerbet is giving a stiff competition to its contemporaries since it has joined forces with Mallinckrodt. The acquisition has led to a streamlined portfolio of MRI and x-ray/CT contrast materials, which now hold center position in this space. GE competes with Omnipaque and Visipaque as a part of its suite of offerings, which account for nearly 12.0% market share. Along with increasing incidence of chronic diseases, rising demand and use of diagnostic imaging modalities is driven by advancements in the underlying technologies. Equipment advancements include innovation such as syringeless injectors, which help in achieving greater accuracy in dose delivery, shorter examination time, and higher patient throughput. Regionally, North America will continue to dominate the contrast media agents market throughout the forecast period. Presence of well-established healthcare infrastructure, availability of advanced technologies as well as recent launch of new contrast media agents for specific indications are contributing to the growth of the region. Further key findings from the report suggest: • In 2016, iodinated contrast agents registered the highest sales in the market due to high penetration of contrast media agents in x-ray and CT procedures, driven by availability of non-ionic stable iodinated agents for improved diagnosis • X-ray/CT modality technique led the market in terms of revenue in 2016 due to its wide acceptance and utilization in the market • Gastrointestinal applications are anticipated to register the fastest growth over the forecast period due to regulatory approval of new products in the U.S. market. For instance, Tagitol V was recently approved by the U.S. FDA for use in adult patients undergoing CTC procedures • On the regional front, North America captured the highest revenue in 2016 owing to presence of well-established healthcare infrastructure and availability of advanced technologies • Europe was the second largest segment in 2016, attributable to increasing usage of diagnostic imaging modalities such as MRI, CT, and ultrasound in the region • Key players in this space are Bayer AG, GE Healthcare, Guerbet, Lantheus Medical Imaging, and Bracco Diagnostics • Most of the key players are focusing on entering untapped regions and expanding their product portfolios through mergers and acquisitions.
Table of Contents Chapter 1 Research Methodology & Scope 1.1 Information Procurement 1.1.1 Purchased database: 1.1.2 GVR's internal database 1.2 Research Methodology 1.3 Geographic scope & assumptions 1.4 Region-wise market calculation 1.4.1 Region-wise market: Base estimates 1.4.2 Global market: CAGR calculation 1.5 Region-based segment share calculation 1.6 List of Secondary Sources Chapter 2 Executive Summary 2.1 Market Snapshot Chapter 3 Market Variables, Trends & Scope 3.1 Market segmentation & scope 3.1.1 Market Drivers Analysis 3.1.1.1 Increasing prevalence of long-term diseases and complex comorbidities 3.1.1.2 Technological advancements 3.1.1.3 Competitive Strategies 3.1.2 Market Restraints Analysis 3.1.2.1 Rising concern over accumulation of linear MRI gadolinium agents in the brain 3.2 Penetration & growth prospect mapping 3.3 Contrast media agents - SWOT Analysis, By Factor (political & legal, economic and technological) 3.4 Industry Analysis - Porter's Chapter 4 Contrast Media Agents Market: Contrast Agent Type Estimates & Trend Analysis 4.1 Contrast media agents market: Contrast Agent Type Movement Analysis 4.1.1 Iodinated contrast media 4.1.1.1 Iodinated contrast agents market, 2016 - 2025 (USD Million) 4.1.2 Barium-based contrast media 4.1.2.1 Barium-based contrast agents market, 2016 - 2025 (USD Million) 4.1.3 Gadolinium-based contrast media 4.1.3.1 Gadolinium contrast agents market, 2016 - 2025 (USD Million) 4.1.4 Microbubble contrast media 4.1.4.1 Microbubble Contrast Agents market, 2016 - 2025 (USD Million) Chapter 5 Contrast Media Agents Market: Modality Type & Trend Analysis 5.1 Contrast media agents market: Modality Type Movement Analysis 5.1.1 X-ray/CT Contrast Agents 5.1.1.1 X-ray/CT contrast agents market, 2016 - 2025 (USD Million) 5.1.2 MRI Contrast Agents 5.1.2.1 MRI contrast agents market, 2016 - 2025 (USD Million) 5.1.3 Ultrasound Contrast Agents 5.1.3.1 Ultrasound contrast agents market, 2016 - 2025 (USD Million) Chapter 6 Contrast Media Agents Market: Application & Trend Analysis 6.1 Contrast media agents market: Applications Movement Analysis 6.1.1 Cardiovascular Disorders 6.1.1.1 Cardiovascular disorders market, 2016 - 2025 (USD Million) 6.1.2 Neurological Disorders 6.1.2.1 Neurological disorders market, 2016 - 2025 (USD Million) 6.1.3 Gastrointestinal Disorders 6.1.3.1 Gastrointestinal disorders market, 2016 - 2025 (USD Million) 6.1.4 Cancer 6.1.4.1 Cancer market, 2016 - 2025 (USD Million) 6.1.5 Nephrological Disorders 6.1.5.1 Nephrological disorders market, 2016 - 2025 (USD Million) 6.1.6 Musculoskeletal Disorders 6.1.6.1 Musculoskeletal disorders market, 2016 - 2025 (USD Million) 6.1.7 Other Applications 6.1.7.1 Others applications market, 2016 - 2025 (USD Million) Chapter 7 Market Categorization 2: Regional Estimates & Trend Analysis, by Test Type 7.1 Contrast media agents market share by region, 2016 & 2025 7.2 North America 7.2.1 North America Contrast media agents market, 2016 - 2025 (USD Million) 7.2.2 U.S. 7.2.2.1 U.S. Contrast media agents market, 2016 - 2025 (USD Million) 7.2.3 Canada 7.2.3.1 Canada Contrast media agents market, 2016 - 2025 (USD Million) 7.3 Europe 7.3.1 Contrast Agent Product Withdrawals 7.3.2 Europe Contrast media agents market, 2016 - 2025 (USD Million) 7.3.3 U.K. 7.3.3.1 U.K. Contrast media agents market, 2016 - 2025 (USD Million) 7.3.4 France 7.3.4.1 France Contrast media agents market, 2016 - 2025 (USD Million) 7.4 Asia 7.4.1 Asia Contrast media agents market, 2016 - 2025 (USD Million) 7.4.2 Japan 7.4.2.1 Japan contrast media agents market, 2016 - 2025 (USD Million) 7.4.3 India 7.4.3.1 India contrast media agents market, 2016 - 2025 (USD Million) 7.5 RoW 7.5.1 RoW contrast media agents market, 2016 - 2025 (USD million) Chapter 8 Competitive Landscape 8.1 Strategy framework 8.2 Market participation categorization 8.3 Company Profiles 8.3.1 Bayer AG 8.3.1.1 Company overview 8.3.1.2 Financial Performance 8.3.1.3 Product overview 8.3.1.4 Strategic initiatives 8.3.1.5 SWOT Analysis 8.3.2 General Electric Company 8.3.2.1 Company overview 8.3.2.2 Financial performance 8.3.2.3 Product overview 8.3.2.4 Strategic initiatives 8.3.2.5 SWOT Analysis 8.3.3 Guerbet 8.3.3.1 Company overview 8.3.3.2 Financial performance 8.3.3.3 Product overview 8.3.3.4 Strategic initiatives 8.3.3.5 SWOT Analysis 8.3.4 Lantheus Medical Imaging, Inc. 8.3.4.1 Company overview 8.3.4.2 Financial performance 8.3.4.3 Product overview 8.3.4.4 Strategic initiatives 8.3.4.5 SWOT Analysis 8.3.5 Bracco Diagnostics, Inc. 8.3.5.1 Company overview 8.3.5.2 Product overview 8.3.5.3 Strategic Initiatives 8.3.5.4 SWOT Analysis Chapter 9 Market Outlook 9.1 Modality Outlook 9.2 Competitive Insights 9.3 Pipeline Analysis
List of Tables TABLE 1 Country share estimation TABLE 2 North America contrast media agents market, by agent type, 2016 - 2025, revenue (USD Million) TABLE 3 North America contrast media agents market, by modality type, 2016 - 2025, by revenue (USD Million) TABLE 4 North America contrast media agents market, by application, 2016 - 2025, revenue (USD Million) TABLE 5 U.S. contrast media agents market, by agent type, 2016 - 2025, revenue (USD Million) TABLE 6 U.S. contrast media agents market, by modality type, 2016 - 2025, by revenue (USD Million) TABLE 7 U.S. contrast media agents market, by application, 2016 - 2025, revenue (USD Million) TABLE 8 Canada contrast media agents market, by agent type, 2016 - 2025, revenue (USD Million) TABLE 9 Canada contrast media agents market, by modality type, 2016 - 2025, by revenue (USD Million) TABLE 10 Canada contrast media agents market, by application, 2016 - 2025, revenue (USD Million) TABLE 11 Europe contrast media agents market, by agent type, 2016 - 2025, revenue (USD Million) TABLE 12 Europe contrast media agents market, by modality type, 2016 - 2025, by revenue (USD Million) TABLE 13 Europe contrast media agents market, by application, 2016 - 2025, revenue (USD Million) TABLE 14 U.K. contrast media agents market, by agent type, 2016 - 2025, revenue (USD Million) TABLE 15 U.K. contrast media agents market, by modality type, 2016 - 2025, by revenue (USD Million) TABLE 16 U.K. contrast media agents market, by application, 2016 - 2025, revenue (USD Million) TABLE 17 France contrast media agents market, by agent type, 2016 - 2025, revenue (USD Million) TABLE 18 France contrast media agents market, by modality type, 2016 - 2025, by revenue (USD Million) TABLE 19 France contrast media agents market, by application, 2016 - 2025, revenue (USD Million) TABLE 20 Asia contrast media agents market, by agent type, 2016 - 2025, revenue (USD Million) TABLE 21 Asia contrast media agents market, by modality type, 2016 - 2025, by revenue (USD Million) TABLE 22 Asia contrast media agents market, by application, 2016 - 2025, revenue (USD Million) TABLE 23 Japan contrast media agents market, by agent type, 2016 - 2025, revenue (USD Million) TABLE 24 Japan contrast media agents market, by modality type, 2016 - 2025, by revenue (USD Million) TABLE 25 Japan contrast media agents market, by application, 2016 - 2025, revenue (USD Million) TABLE 26 India contrast media agents market, by agent type, 2016 - 2025, revenue (USD Million) TABLE 27 India contrast media agents market, by modality type, 2016 - 2025, by revenue (USD Million) TABLE 28 India contrast media agents market, by application, 2016 - 2025, revenue (USD Million) TABLE 29 RoW contrast media agents market, by agent type, 2016 - 2025, revenue (USD Million) TABLE 30 RoW contrast media agents market, by modality type, 2016 - 2025, by revenue (USD Million) TABLE 31 RoW contrast media agents market, by application, 2016 - 2025, revenue (USD Million)
List of Figures FIG. 1 Market research process FIG. 2 Information procurement FIG. 3 Value chain based sizing & forecasting FIG. 4 QFD modelling for market share assessment FIG. 5 Market summary, 2016 FIG. 6 Market trends & outlook FIG. 7 Market segmentation & scope FIG. 8 Market driver relevance analysis (Current & future impact) FIG. 9 Market restrain relevance analysis (Current & future impact) FIG. 10 Penetration & growth prospect mapping FIG. 11 SWOT Analysis, By Factor (political & legal, economic and technological) FIG. 12 Contrast media agents market type outlook: key takeaways FIG. 13 Contrast media agents market: Agent type movement analysis FIG. 14 Global Iodinated contrast agents market, 2016 - 2025 (USD Million) FIG. 15 Barium-based contrast agents market, 2016 - 2025 (USD Million) FIG. 16 Global gadolinium contrast agents market, 2016 - 2025 (USD Million) FIG. 17 Global microbubble contrast agents market, 2016 - 2025 (USD Million) FIG. 18 Contrast media agents market, modality type outlook: key takeaways FIG. 19 Contrast media agents market: Modality type movement analysis FIG. 20 Global x-ray/CT contrast agents market, 2016 - 2025 (USD Million) FIG. 21 Global MRI contrast agents market, 2016 - 2025 (USD Million) FIG. 22 Global ultrasound contrast agents market, 2016 - 2025 (USD Million) FIG. 23 Contrast media agents market application outlook key takeaways FIG. 24 Contrast media agents market: Applications movement analysis FIG. 25 Global cardiovascular disorders market, 2016 - 2025 (USD Million) FIG. 26 Global neurological disorders market, 2016 - 2025 (USD Million) FIG. 27 Global gastrointestinal disorders market, 2016 - 2025 (USD Million) FIG. 28 Global cancer market, 2016 - 2025 (USD Million) FIG. 29 Global nephrological disorders market, 2016 - 2025 (USD Million) FIG. 30 Global musculoskeletal disorders market, 2016 - 2025 (USD Million) FIG. 31 Global other applications market, 2016 - 2025 (USD Million) FIG. 32 Regional market place: Key takeaways FIG. 33 Regional outlook, 2016 & 2025 FIG. 34 North America Contrast media agents market, 2016 - 2025 (USD Million) FIG. 35 U.S. Contrast media agents market, 2016 - 2025 (USD Million) FIG. 36 Canada contrast media agents market, 2016 - 2025 (USD Million) FIG. 37 Europe Contrast media agents market, 2016 - 2025 (USD Million) FIG. 38 U.K. contrast media agents market, 2016 - 2025 (USD Million) FIG. 39 France contrast media agents market, 2016 - 2025 (USD Million) FIG. 40 Asia Contrast media agents market, 2016 - 2025 (USD Million) FIG. 41 Japan contrast media agents market, 2016 - 2025 (USD Million) FIG. 42 India contrast media agents market, 2016 - 2025 (USD Million) FIG. 43 RoW contrast media agents market, 2016 - 2025 (USD Million) FIG. 44 Strategy framework FIG. 45 Participant categorization FIG. 46 SWOT Analysis (Bayer) FIG. 47 SWOT Analysis (GE) FIG. 48 SWOT Analysis (Guerbet) FIG. 49 SWOT Analysis (Lantheus) FIG. 50 SWOT Analysis (Bracco)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.